Objectives	To be able to assess, diagnose and treat patients with complications/toxicities of anticancer therapies
Awareness	Recognition that different classes of cancer treatments (cytotoxic, (anti)hormonal, targeted and immunotherapy) are associated with a different spectrum of complications/toxicities Appreciation that toxicities of different anticancer therapies can be overlapping Awareness that newer classes of cancer drug therapy (targeted therapy, immunotherapy) are associated with some complications not seen with more traditional therapies (cytotoxic, (anti)hormonal) Appreciation that organs and body systems can be affected by complications/toxicities with variable frequency, severity and chronicity Recognition that severity and chronicity will have implications for management decisions Awareness that complications/toxicities can be acute or chronic Awareness that complications/toxicities can be temporary or permanent Appreciation that drug interactions can contribute to complications/toxicities of treatment Recognition that clinical assessment is of critical importance in the evaluation of treatment-related adverse events Awareness of the existence of the available diagnostic tests Awareness that the complications/toxicities of treatment can have physical and psychological impacts on the patient Recognition that management is often multidisciplinary Awareness that preventative/prophylactic measures exist for some complications/toxicities Appreciation that complications/toxicities from therapy can impact the deliverability of subsequent anticancer treatment
Knowledge	Familiarity with the complications/toxicities associated with classes of anticancer therapy (cytotoxic, (anti)hormonal, targeted and immuno-therapy) and with single agents Familiarity with the frequency with which adverse events occur, how severity can be assessed and the natural history of such events Understanding that prescription, over-the-counter and complementary medicines have the potential to interact with anticancer therapy and thus contribute to adverse events Understanding of the diagnostic approach to complications of therapy, in particular the relevant history, examination and investigational findings Familiarity with the spectrum of therapeutic options available for complications of treatment, including pharmacological and non-pharmacological strategies Knowledge of evolving treatment paradigms for targeted therapy and immunotherapy Understanding that many other healthcare professionals will have a role in the diagnosis and management of the complications/toxicities of treatment, including medical, nursing, pharmacy and allied health personnel Understanding that effective prevention and/or prophylactic strategies can be employed to reduce the frequency and/or severity of some complications/toxicities Familiarity with potential mechanisms of complications/toxicities Familiarity with potential drug interactions contributing to complications/toxicities and the mechanisms of these interactions Familiarity with the psychological impact of treatment-related adverse events and the supportive measures available to the patient Understanding how the complications/toxicities of treatment will impact future delivery of anticancer therapy and when a dose delay, dose modification or treatment cessation may be applied
Skills	Ability to contribute actively to a wide variety of presentations of complications/toxicities of different classes of anticancer therapy Ability to perform a thorough history and clinical examination Ability to contribute actively to present patient cases Ability to discuss potential diagnostic investigations including the merits and limitations of the tests Ability to contribute to discussions on management strategies with reference to pharmacological and non-pharmacological methods Ability to discuss the role of other healthcare professionals for each scenario Ability to discuss prophylactic/preventative measures that can be instituted to protect patient safety